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Abstract PYRIN- and CARD-containing proteins belong to a
recently identi¢ed protein family involved in the regulation of
apoptosis and in£ammatory processes. Variations in the gene
products of the family members PYPAF1 and NOD2/
CARD15 have been associated with several autoin£ammatory
diseases. We could identify the mouse orthologs of PYPAF1,
PYPAF5, NOD1, NOD2 and the rat ortholog of PYPAF5.
Intriguingly, we found that PYPAF5 has been reported previ-
ously not only as regulator of NF-UB and caspase-1, but also as
angiotensin II and vasopressin receptor. In particular, based on
a comprehensive sequence analysis, we propose a structural
model for this hormone receptor that is di¡erent from the model
suggested previously.
. 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The expressed human proteins PYPAF1, PYPAF5, NOD1,
and NOD2, all with as yet unknown biological functions, are
members of the same protein family putatively involved in the
regulation of apoptosis and in£ammatory immune responses
[1^4]. The family members share a similar domain architecture
consisting of one or several N-terminal PYRIN (as in the
protein pyrin) or CARD (caspase activating recruitment) ho-
mologous domains, one intermediate NTPase oligomerization
domain, and one C-terminal LRR (leucine-rich repeat) do-
main (Fig. 1).
Several missense mutations in the PYPAF1 and NOD2
genes have been identi¢ed to be independently associated
with clinically distinct diseases, which, however, have shared
pathophysiological characteristics of autoin£ammatory pro-
cesses [5]. Genetic variations in the PYPAF1 gene have been
linked to Muckle^Wells syndrome, familial cold autoin£am-
matory syndrome, also known as familial cold urticaria, and
chronic infantile neurological cutaneous and articular syn-
drome. Variants in the NOD2 gene have been found to confer
susceptibility to Blau syndrome and one of the two main types
of chronic in£ammatory bowel disease, Crohn’s disease.
Experimental data suggests that the described family mem-
bers participate in the upstream regulation of pro-in£amma-
tory signaling pathways via the activation of NF-UB and pro-
caspase-1 through the PYRIN/CARD domains; caspase-1 is
known to process pro-interleukin-1L and pro-interleukin-18
into active cytokines. The generic function of the LRR do-
main is still unknown, but the domain is proposed to work as
a receptor in analogy to the LRR domain of mammalian
transmembrane Toll-like receptors and the NTPase-LRR do-
mains of cytoplasmic plant disease resistance gene products
[6^9]. The LRR domain of NOD1 and NOD2 appears to
mediate the responsiveness to bacterial lipopolysaccharides
[10].
In the following, we will brie£y report the computational
identi¢cation of the mouse orthologs of human PYPAF1,
NOD1, NOD2, which also allowed us to discover the mouse
and rat ortholog of human PYPAF5. We will then focus on a
detailed discussion of two seemingly contradictory functional
roles that have been associated previously with human and rat
PYPAF5. This protein has been reported to work as solely
cytosolic NF-UB activator and as seven-transmembrane hor-
mone receptor. Particularly, we will present structural evi-
dence that the LRR domain of PYPAF5 does not contain
any transmembrane helix in contrast to another proposed
G-protein coupled receptor (GPCR) model.
2. Materials and methods
Sequence searches in the NCBI NR and SWISS-PROT/TrEMBL
databases were performed by the BLAST suite of programs. We also
used the genomic synteny view and other tools such as gene prediction
programs, which are o¡ered by the Ensembl Project and the UCSC
Genome Browser, to determine the mammalian orthologs of human
genes and the corresponding protein sequences. In addition, we could
¢nd the rat ortholog of human PYPAF5 via the whole genome com-
parative analysis of the Berkeley Genome Pipeline. Expressed se-
quence tags and other sequence fragments contained in NCBI data-
bases give su⁄cient evidence for the expression of the identi¢ed genes.
Sequence alignments were computed by CLUSTAL W and im-
proved by minor manual modi¢cations. Figures with sequence align-
ments were prepared using the web tool ESPript. The performance
of seven of the used transmembrane prediction methods (DAS,
HMMTOP2, PHDhtm, PRED-TMR2, SOSUI, TMHMM2, Top-
Pred2) has been benchmarked comprehensively [11] and reaches an
accuracy of over 80 up to 99%. Generally, at least one of the seven
methods is able to recognize several transmembrane helices of some
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GPCR properly. Web links to online bioinformatics services utilized
in this study are listed in Web Note A (the online version of this
article contains supplementary material).
3. Results and discussion
3.1. Identi¢cation of mammalian orthologs
Using gene prediction tools and additional information
contained in genome and sequence databases, we could iden-
tify the mouse orthologs of PYPAF1, PYPAF5, NOD1,
NOD2, and the rat ortholog of PYPAF5. Sequence align-
ments of the PYPAF1/PYPAF5 and the NOD1/NOD2 ortho-
logs (Web ¢gs. A and B, respectively) reveal a high degree of
sequence identity of over 75% between corresponding species
orthologs (Web Table A).
3.2. Functional roles of PYPAF5
We discovered that PYPAF5 has been associated in the
literature with two distinct functional roles and cellular local-
izations in di¡erent cell types. Like PYPAF1, human PY-
PAF5 has been reported to be recruited by the PYRIN-
CARD protein ASC to distinct cytoplasmic loci through the
PYRIN domain. It synergistically activates NF-UB and pro-
caspase-1 when co-expressed with ASC [4]. In consistency
with the observed involvement of human PYPAF5 in in£am-
matory signaling, its expression has been described to be re-
stricted to peripheral blood leukocytes.
We also identi¢ed an incomplete sequence fragment of rat
PYPAF5, which has been obtained from cDNA, encompass-
ing solely the LRR domain. Surprisingly, it has been reported
previously from renal epithelial cells as transmembrane dual
angiotensin II (AII) and arginine vasopressin (AVP) receptor
(AVR) with characteristics of AT1 and V2 isoreceptor sub-
types coupled to the adenylate cyclase system [12,13].
3.3. Transmembrane helices
The authors of the original publication on AVR [12], lack-
ing the complete PYPAF5 sequence, proposed a hormone
receptor model of a GPCR [14] with seven transmembrane
helices for the AVR (the LRR domain of PYPAF5) based
on the Kyte^Doolittle hydropathy index. To investigate this
issue further, we plotted this index both for the complete rat
PYPAF5 protein sequence and only for its LRR domain (Fig.
3A and B, respectively). However, the hydropathy index in
the plot for the LRR domain is always under 1.2 and never
exceeds the hydrophobicity threshold of 1.6 characteristic of
transmembrane helices as advised by Kyte and Doolittle [15].
We obtained similar results for the LRR domain with other
hydropathy indices and parameters, using the tool Prot-
Scale.
It seems that the authors on AVR ignored the common use
of a hydrophobicity threshold for potential transmembrane
regions. Above all, none of 12 state-of-the-art prediction serv-
ers (see Web Table A) detects any transmembrane helix in the
AVR sequence with a reliable con¢dence value. In accordance
with these ¢ndings, we did not detect any homology to other
GPCRs and AII or AVP receptors deposited in the GPCR
database.
In contrast, plotting the hydropathy index for the complete
PYPAF5 protein sequence indicates a rather hydrophobic re-
gion between the NTPase and LRR domain from N376 to
M400 (Fig. 3A), possibly containing a single-transmembrane
helix. This ¢nding is con¢rmed for the same region with a
reliable score of 2.0 by the more advanced transmembrane
prediction method TopPred2. However, the TMHMM2 pre-
diction server returns a less signi¢cant probability value of
0.01, and similar results are obtained from other state-of-
the-art transmembrane prediction servers. As the identi¢ed
hydrophobic region is highly conserved in PYPAF1 (Web
¢g. A), which has been described only as a cytosolic protein
like NOD1 and NOD2 [3], we cannot predict any transmem-
brane helix in PYPAF5 with con¢dence.
3.4. Multiple sequence alignment
Finally, we assembled a multiple sequence alignment of the
LRR domains of human PYPAF1, human PYPAF5, rat
AVR/PYPAF5, human NOD1, human NOD2. We annotated
the alignment with the secondary structures predicted by the
PSIPRED server (Fig. 2). In addition, we included the se-
quence and the crystallographically determined secondary
structure of the bovine ribonuclease inhibitor (RNI) of ribo-
nuclease A into the alignment. A BLAST search with the
AVR sequence in the PDB database returns a signi¢cant E-
value of 10320 to RNI. This result implicates an evolutionary
relationship and a similar three-dimensional structure. In ad-
dition, the secondary structure annotations of the aligned pro-
teins agree well with each other (Fig. 2). A sequence identity
matrix derived from the multiple sequence alignment gives
signi¢cantly high values (Web Table B).
Apparently, the secondary structure prediction of AVR dis-
agrees substantially with the seven-transmembrane model pro-
posed in the original publication, but matches to the RNI
structure.
PYRIN NTPasePYPAF5
CARD NTPaseNOD1
CARDCARD NTPaseNOD2
PYRIN NTPasePYPAF1 LRR
LRR
LRR
LRR
Fig. 1. Domain architectures of PYPAF1, PYPAF5, NOD1, and
NOD2.
C
Fig. 2. Multiple sequence alignment of the LRR domains of human PYPAF1, human PYPAF5, rat PYPAF5/AVR, bovine RNI, human
NOD1, and human NOD2. The secondary structure of RNI and the corresponding predictions by the PSIPRED server for the other proteins
are depicted in the lower part (K-helices are represented by curled lines, L-strands by arrows). The alignment columns with strictly conserved
residues are highlighted in dark gray boxes, those in which more than 65% of the residues are physico-chemically equivalent are shown in light
gray boxes. Dashed lines above the alignment indicate the positions of the putative AVP and AII binding sites near the N- and C-terminus, re-
spectively, of AVR. Solid circles denote a conserved, highly acidic region in PYPAF1 and PYPAF5. Triangles mark the two sequence varia-
tions N119S and C163R associated with sodium-induced AVR dysfunction. The sequence and the secondary structure of bovine RNI was ob-
tained from the DSSP database via the PDB identi¢er 1dfj, chain I. The SWISS-PROT/TrEMBL or accession numbers of the aligned proteins
are as follows: human PYPAF1/CIAS1/CRYOPYRIN/NALP3, Q96P20; human PYPAF5, P59044; rat PYPAF5/AVR, MGI: 2448892/
Q63035; human NOD1/CARD4, Q9Y239; NOD2/CARD15/IBD1, Q9HC29.
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The SCOP classi¢cation of protein structures indicates that
the horseshoe fold of the RNI is also shared by other proteins
of distinct functions such as the Ran GTPase activating pro-
tein RanGAP [16]. Interestingly, Ran has been observed to be
involved in LPS-mediated signal transduction [17], which may
provide some functional link between NOD1/NOD2 and Ran-
GAP. Apart from that, the LRR domain of PYPAF1 and
PYPAF5 contains the unusual, but conserved sequence fea-
ture of a highly acidic region (Fig. 2) as also described in the
potato R gene product HERO with broad spectrum resistance
to cyst nematodes [18]. This ¢nding strongly supports the
evolutionary relationship of the innate immune system of
mammals and plants.
Based on sequence similarity to putative binding sites of
other AII and AVP receptors and experimental observations
on AVR, Ruiz-Opazo et al. suggested two hormone binding
sites for AII and AVP in the LRR domain of PYPAF5 [12].
Because the identi¢ed regions appear moderately conserved in
the multiple sequence alignment of LRR domains (Fig. 2),
other family members homologous to PYPAF5 may also rec-
ognize AII and AVP. Interestingly, it has been hypothesized
that AII and AVP are involved in apoptosis and neuroendo-
crine immunomodulation, respectively [19,20]. Apart from
that, the sequence variations N119S and C163R of AVR,
which exhibit sodium-induced receptor dysfunction in a hy-
pertension rat model [21], seem to be preserved in some other
homologs of PYPAF5 (Fig. 2).
4. Conclusions
The identi¢ed mouse and rat orthologs of human PYRIN-
and CARD-containing proteins can be helpful, for instance,
in establishing animal models of the involved autoin£amma-
tory diseases. In addition, we propose a new structural model
for the renal AVR/PYPAF5 with an extracellular LRR do-
main, whose three-dimensional fold is similar to the structure
of RNI. Our results challenge the previous model of PYPAF5
as a seven-transmembrane glycoprotein receptor [22]. Apart
from that, PYPAF5 has been reported as cytoplasmic protein
and transmembrane receptor, associated with distinct func-
tions [4,12]. This contradiction should be resolved by addi-
tional experimental results on the cellular locations and func-
tional roles of PYPAF5.
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